News Formal

A revolution in weight loss treatment may force a reckoning for food and beverage companies

  • 📰 CNBC
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 72%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

Morgan Stanley said a sizeable demographic representing a disproportionate share of food consumption will be changing their habits due to weight loss drugs.

If you have heard that new weight loss medications mean you can eat all the junk food you want and still lose weight — you've heard wrong. Still, it's undeniable that a huge shift is underway in how obesity and overweight is being treated by doctors due to a new class of drugs known as GLP-1 agonists. The drugs are more successful in achieving weight loss and appear to have fewer side effects than previous generations of obesity treatments.

Currently, it expects 40 million people have health insurance plans that would cover the medication. "Manufacturer supply constraints and the evolution of insurance coverage will likely impact broad [anti-obesity medication] accessibility, and this is a key question around use of these mediations," the analysts said. "It is unclear how insurance coverage will expand over time; it may depend on comorbidity trials .

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 12. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Morgan Stanley says buy 'top’ stocks like Apple to fight the growing market malaiseMorgan Stanley said it likes stocks like Apple as market uncertainty mounts.
ソース: CNBC - 🏆 12. / 72 続きを読む »